Somia Iqtadar

Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

Francesco Di Pierro, Somia Iqtadar, Amjad Khan et al. · International Journal of General Medicine · 2021 · 172 citations · Full text

Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial

Amjad Khan, Somia Iqtadar, Sami Ullah Mumtaz et al. · Frontiers in Pharmacology · 2022 · 52 citations · Full text

Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial

Francesco Di Pierro, Amjad Khan, Somia Iqtadar et al. · Frontiers in Pharmacology · 2023 · 51 citations · Full text

Role of Vitamin D in reducing number of acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD) patients

Dur Muhammad Khan, Aziz Ullah, Fawad Ahmad Randhawa et al. · Pakistan Journal of Medical Sciences · 2017 · 37 citations · Full text

Clinical Effects of Streptococcus salivarius K12 in Hospitalized COVID-19 Patients: Results of a Preliminary Study

Francesco Di Pierro, Somia Iqtadar, Sami Ullah Mumtaz et al. · Microorganisms · 2022 · 23 citations · Full text